PUBLISHER: Grand View Research | PRODUCT CODE: 2112282
PUBLISHER: Grand View Research | PRODUCT CODE: 2112282
The global maggot debridement market size was valued at USD 15.7 million in 2025 and is projected to grow from USD 17.3 million in 2026 to USD 35.0 million by 2033, at a CAGR of 10.6% from 2026 to 2033. North America held the largest revenue share of 47.5% in 2025. The demand for maggot debridement therapy (MDT), which involves using disinfected maggots to remove dead tissue and bacteria from wounds, is rising.
The increasing prevalence of chronic wounds, a rising geriatric population, and the growing acceptance of bio-based therapies in clinical applications drive market growth. The increasing prevalence of diabetes and obesity is responsible for growing incidences of chronic wounds such as diabetic foot ulcers, venous ulcers, and pressure ulcers, which pose significant challenges to patients worldwide.
Maggot debridement therapy promotes healing and has proven to be a safe and effective alternative to traditional surgical removal techniques. An additional driving force for market growth is the aging population, prone to chronic wounds due to age-related physiological changes and comorbidities. MDT offers a less invasive approach as it is particularly useful for elderly patients who find invasive procedures difficult. This demographic shift is expected to significantly impact the market as healthcare providers seek effective treatments that address the specific needs of geriatric patients.
Global Maggot Debridement Market Report Segmentation
This report forecasts revenue growth at the global, regional & country levels and analyzes the latest industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global maggot debridement market report based on administration, application, end use, and region: